WASHINGTON, March 04, 2022 (GLOBE NEWSWIRE) — Vantage Market Research’s recent analysis of the Global Lung in Vitro Model Market finds that rising attention to the development of animal model alternatives, advancement in cell culture technology, and the development of new 3D in vitro models are some of the major parameters in spurring the growth of Lung in Vitro Model Market in recent years. The total Global Lung in Vitro Model Market is estimated to reach USD 976.1 Million by 2028.
The market stood at a revenue of USD 275.1 Million in the year 2021, and is expected to exhibit a Compound Annual Growth Rate (CAGR) of 17.1%, states Vantage Market Research, in a report, titled “Lung in Vitro Model Market by Type (2D Cell Models, 3D Cell Models), by Application (Drug Screening, Toxicology, Others), by Region (North America, Europe, Asia Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)”.
Please Check Out Our Free Sample Reports and Make a More Informed Decision:
Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/lung-in-vitro-model-market-1337/request-sample
(Sample reports are a great way to test our in-depth reports or study before you make a purchase)
The newly updated, 115+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
We offer these reports in PDF format so you can read them on your computer and print them out.
Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.
Introduction of 3D in Research Methods to Reproduce the Human Tissues/Organs Propels the Market
Lungs are a very important organ in the human body and disfunctioning of this organ create great damage. In vitro model is used to address the introduction of 3D in research methods to reproduce the human tissues/organs. It is also used in drug screening and provide better alternatives for reducing experiments on animals. Thus, all these benefits are responsible for augmenting the growth of Lung in Vitro Model Market in recent years. In addition, increasing occurrences of lung diseases such as, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), asthma, and lung cancer is propelling the growth of Lung in Vitro Model Market in coming years. Furthermore, stringent regulations to minimizing animal experimenting is also expected to propel the growth of Lung in Vitro Model Market over the projected year.
Emergence of Advanced 3D in Vitro Model Fuels the Market Demand
The major consumer of lung in vitro model are research organizations & academics, government research institutes, life-science companies and biotechnology & pharmaceutical companies. The high usage of this model in various organization is accelerating the growth of Lung in Vitro Model Market in upcoming years. In addition, rising research projects on lung disorders, emergence of advanced 3D in vitro models and rising adoption of 3D cell culture are some major factors that influencing the growth of Lung in Vitro Model Market during projected years.
Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/lung-in-vitro-model-market-1337/0
Benefits of Purchasing Lung in Vitro Model Market Reports:
Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
Assured Quality: Focuses on accuracy and quality of reports.
Incomparable Skills: Analysts provide in-depth insights into reports.
COVID-19 Impact Analysis:
The COVID-19 outbreak has affected various industries worldwide. Governments across the world implemented strict lockdown measures and social distancing norms in order to restrict the swift spread of the pandemic. Manufacturing facilities around the world were shut down during the initial stages of the pandemic. Moreover, the economic crisis after the pandemic might lead to a significant delay in the commercial roll-out of the electronics industry. Small and medium-scale companies are the backbone of technology providers and are witnessing a steep drop in revenue since the emergence of the pandemic in 2020. Hence, market players faced numerous challenges as disruptions in the supply chain were observed. However, things will improve in the second half of 2022 as more supplies will come online. The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data points:
Impact Assessment of COVID-19 Pandemic
Middle East & Africa
Quarterly Market Revenue Forecast by Asia Pacific 2020 & 2021
Key Strategies Undertaken by Companies to Tackle COVID-19
Long Term Dynamics
Short Term Dynamics
Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/lung-in-vitro-model-market-1337
The Report on Lung in Vitro Model Market Highlights:
Assessment of the market
COVID Impact Analysis
Historic Data, Estimates and Forecast
Global and Regional Dynamics
North America Dominates the Market
North America accounted for the largest share of Lung in Vitro Model Market during forecast period. Large presence of market players, established healthcare infrastructure and growing animal welfare regulations & related awareness programs are some of the key factors that bolstering the growth of Lung in Vitro Model Market in this region. In addition, rising research activities, supportive healthcare policies, maximum investments for new product development and favourable government initiatives are expected to drive the Lung in Vitro Model Market demand in this region.
List of Prominent Players in the Lung in Vitro Model Market:
Mat Tek Corporation (US)
Tiss Use (Switzerland)
CN Bio Innovations (UK)
Browse market data Tables and Figures spread through 120 Pages and in-depth TOC on "Lung in Vitro Model Market by Type (2D Cell Models, 3D Cell Models), by Application (Drug Screening, Toxicology, Others), by Region (North America, Europe, Asia Pacific, Latin America) – Global Industry Assessment (2016 – 2021) & Forecast (2022 – 2028)" View detailed Research Report here – https://www.vantagemarketresearch.com/press-release/lung-in-vitro-model-market-830013
September, 2021: BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol. The three companies have joined forces to present customers a first of its kind full-service 3D biomanufacturing and in vitro analysis service.
June, 2018: InSphero AG, announced that they have received USD 10 million for their research on discovery platforms for cancer and metabolic diseases. InSphero AG is an innovator and a provider of 3D cell-based platforms in efficacy testing and drug discovery.
Key questions answered in the report:
Which regional market will show the highest and rapid growth?
Which are the top five players of the Lung in Vitro Model Market?
How will the Lung in Vitro Model Market change in the upcoming six years?
Which application and product will take a lion’s share of the Lung in Vitro Model Market?
What is the Lung in Vitro Model market drivers and restrictions?
What will be the CAGR and size of the Lung in Vitro Model Market throughout the forecast period?
This market titled “Lung in Vitro Model Market” will cover exclusive information in terms of Geographic Segmentation, Regional Analysis, Forecast, and Quantitative Date – Units, Key Market Trends, and various others as mentioned below:
Market Size in 2021
USD 275.1 Million
Projected Market Size in 2028
USD 976.1 Million
CAGR Growth Rate
CAGR of 17.1% From 2022 – 2028
2016 – 2020
2022 – 2028
• 2D Cell Models
• 3D Cell Models
• Drug Screening
Quantitative Data – Units
Revenue in USD Million/Billion and CAGR from 2022 to 2028
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered
10 companies with scope for including additional 15 companies upon request
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization of the Report:
The report can be customized as per client needs or requirements. For any queries, you can contact us on email@example.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
Download Free Sample Report Now @ https://www.vantagemarketresearch.com/lung-in-vitro-model-market-1337/request-sample
Browse More Related Report:
Single-use Bioreactors Market:- https://www.vantagemarketresearch.com/industry-report/singleuse-bioreactors-market-1351
Epigenetics Market:- https://www.vantagemarketresearch.com/industry-report/epigenetics-market-1339
Spatial Genomics and Transcriptomics Market:- https://www.vantagemarketresearch.com/industry-report/spatial-genomics-and-transcriptomics-market-1334
Structural Biology and Molecular Modeling Market:- https://www.vantagemarketresearch.com/industry-report/structural-biology-and-molecular-modeling-market-1333
About Vantage Market Research:
Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.
Follow Us on LinkedIn: https://www.linkedin.com/company/vantage-market-research/
Follow Us on Twitter: https://twitter.com/vantagemarketr
6218 Georgia Avenue NW Ste 1 – 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases
Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs
The U.S. government may throw its weight (and its money) behind expanding lithium production tomorrow.
Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk posted in a Twitter thread on Monday advising followers to own “physical things” when inflation is high. In the tweet, Musk said “As a general principle, for those looking for advice from this thread, it is generally better to own physical things like a home or stock in companies you think make good products, than dollars when inflation is high. I still own & won’t sell my Bitcoin, Ethereum or Doge fwiw.” The biggest takeaway for some followers seems to ha
Americans may have more help in the fight to save for retirement after House passes bipartisan retirement legislation.
The SECURE Act 2.0 — a follow up to the 2019 bill that made myriad changes to the way Americans save for retirement — passed in the House this week, meaning that if it gets approved by the Senate it … Continue reading → The post Your 401(k) Could Soon Get a $10,000 Catch-up Boost appeared first on SmartAsset Blog.
We all know how the stock market started out 2022 with a sudden reversal of last year’s bull run. By the end of February, it was clear that stocks had entered correction territory; the sell-off was broad-based, across all segments of the market. But is the sell-off over? There are indications that may be the case. Since bottoming out on March 14, the market has staged a strong rebound, and year-to-date is no longer in correction territory. The S&P 500 is up 10% in that period, and the NASDAQ, wh
Clinical-stage biopharmaceutical company Geron (NASDAQ: GERN) saw its shares jump 23.4% on Wednesday. Geron was last this high on Nov. 15, and it has a 52-week low of $0.99 and a 52-week high of $2.23. The stock jumped on the type of news that ordinarily might make it fall — the company announced it was making a public offering of common stock to raise money.
The stock market finally took a break on Wednesday from its string of big wins. Wall Street remained hopeful for favorable resolutions on key issues like inflation and the war in Ukraine, but that didn't stop the Dow Jones Industrial Average (DJINDICES: ^DJI), Nasdaq Composite (NASDAQINDEX: ^IXIC), and S&P 500 (SNPINDEX: ^GSPC) from giving up some ground after an impressive rally over the past few weeks.
Oil prices dived more than $5 a barrel on Thursday as the United States is considering the release of up to 180 million barrels from its strategic petroleum reserve (SPR) over several months to calm soaring crude prices. U.S. West Texas Intermediate futures for May delivery fell $6.06, or 5.6%, to $101.76 a barrel after earlier slipping to a low of $100.85. U.S. President Biden will give remarks later on Thursday announcing the plan, three sources said, aimed at lowering gasoline prices that have risen to records following Russia's invasion of Ukraine.
The FDA has issued a complete response letter (CRL) to Akebia Therapeutics Inc's (NASDAQ: AKBA) marketing application (NDA) for vadadustat for anemia due to chronic kidney disease (CKD). Vadadustat is an investigational oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor. The FDA issues a CRL to indicate that the review cycle for an application is complete and that the application is not ready for approval in its present form. The FDA concluded that the data in the marketing appl
Even with the economic reopening, the home improvement retailer's fundamentals are still robust.
Russian oil tankers have been disappearing from tracking systems. Someone is buying that crude and figuring out who is difficult.
The Dow Jones moved higher amid positive Russia-Ukraine cease-fire talks. Visa and Nike stock impressed. Robinhood stock exploded.
Jim Cramer says not every company can pull off the transition from cyclical to secular growth stock.
THE MONEYIST Dear Quentin, My husband of seven years owns a home in Minnesota and has a mortgage. I own a home in Florida with no mortgage. We have no savings or retirement accounts. Should I pull my equity from my home in Florida to start a savings account for us? I’m working and my husband is retired.
(Bloomberg) — The 11% surge in U.S. stocks in the past two weeks has the hallmarks of a bear-market rally that might give way to deeper losses.Most Read from BloombergUkraine Update: U.S. Doubts Russian Pullback; Lavrov in ChinaUkraine Update: Kyiv Seeks Cease-Fire Deal in Russia TalksHome Prices Suggest Housing Bubble Brewing in U.S., Dallas Fed SaysThe Fed Has Made a U.S. Recession InevitableWorld’s Longest Passenger Flight Plans to Avoid Russian SkiesThat’s the conclusion of analysts at Bank
Count on Beyoncé to unveil the best Oscars after-party dress last. Early today, Bey dropped photos of herself in the nude sheer dress she wore to her and Jay-Z's after party.
Apple's stock has been rocking of late. Here's why.
(Bloomberg) — Oil tumbled on signs the Biden administration is considering tapping U.S. reserves in a potentially massive release to tackle rising inflation and supply shortages following Russia’s invasion of Ukraine.Most Read from BloombergNever Had Covid? You May Hold Key To Beating the VirusPutin ‘Misinformed’ by Advisers on the War, White House SaysApple and Meta Gave User Data to Hackers Who Used Forged Legal RequestsHome Prices Suggest Housing Bubble Brewing in U.S., Dallas Fed SaysBiden
On March 28, Tesla announced that it will split its stock for the second time in two years. The decision also follows similar plans from Amazon and Google parent company Alphabet to do 20-for-1 stock splits, drastically lowering their respective share price. If approved, Amazon stock will drop from about $3300 to $165 while Alphabet will drop from about $2800 to $140.
Cathie Wood's Ark bought and sold shares of electric-vehicle makers and snapped up shares of two biotech companies.